In this conversation, we sit down with Michelle Lupton -Head of Neurogenetics and Dementia at QIMR Berghofer Medical Research Institute and dive into how genetics and scientific research are transforming our understanding of Alzheimer’s disease. We look at the powerful role genetics plays—not only in identifying risk factors but also in guiding research that could unlock new approaches to treatment and prevention. Alongside the science, we reflect on the human side of dementia, emphasizing the importance of living in the moment and finding meaning in everyday experiences, even as memory and cognition change.

Michelle shares her insights on groundbreaking genetic studies, explaining how they shed light on the complex biological processes behind Alzheimer’s. Her perspective highlights not just the challenges but also the progress being made, giving us reasons to remain hopeful about the future of treatment and care.